Podcasts
-
Mike on Medtech: Beyond 510(k)/PMA—Breakthrough Devices Program
Sean Fenske and Mike Drues discuss a relatively new program from the FDA—the Breakthrough Devices Program—and what it offers to medtech manufacturers.Sean Fenske, Editor-in-Chief 08.06.19
-
Mike on Medtech: Beyond 510(k)/PMA—De Novo 101
Sean Fenske and Mike Drues discuss the third most common regulatory pathway—the De Novo—clearing up details about its advantages and when it's used.Sean Fenske, Editor-in-Chief 07.02.19
-
Mike on Medtech: The NYT Editorial Board Statement
Sean Fenske and Mike Drues discuss the recent comments made by the Board about the medical device industry and FDA.Sean Fenske, Editor-in-Chief 06.17.19
-
Mike on Medtech: The Alternative Summary Reporting Program
Sean Fenske and Mike Drues discuss the recently announced cancellation of the alternative summary reporting program and the reasons for it.Sean Fenske, Editor-in-Chief 05.24.19
-
Mike on Medtech: A Pre-Sub for 483s, Part 2
Sean Fenske and Mike Drues continue a discussion regarding a recently released FDA guidance focused on communication with the agency over a 483.Sean Fenske, Editor-in-Chief 05.09.19
-
Mike on Medtech: A Pre-Sub for 483s, Part 1
Sean Fenske and Mike Drues discuss a recently released FDA guidance that outlines a specific communication protocol to address certain 483s with the agency.Sean Fenske, Editor-in-Chief 05.09.19
-
Materials
Mike on Medtech: FDA's Material Evaluation
Sean Fenske and Mike Drues discuss the FDA's announcement that the agency will review materials used in the manufacture of medical devices.Sean Fenske, Editor-in-Chief 04.02.19
-
Mike on Medtech: 510(k) Modernization
Sean Fenske and Mike Drues discuss the potential changes coming to the 510(k) regulatory pathway and examine the issues around predicate devices.Sean Fenske, Editor-in-Chief 01.25.19
-
Mike on Medtech: Personalized Healthcare
Sean Fenske and Mike Drues discuss the impact personalized healthcare is having on the medical device industry and the challenges faced.Sean Fenske, Editor-in-Chief 01.03.19
-
Neurological
Mike on Medtech: Holiday Wish List, Part 2
Sean Fenske and Mike Drues continue their discussion of the industry's "wish list" for the coming year and beyond.Sean Fenske, Editor-in-Chief 12.11.18
-
Mike on Medtech: Holiday Wish List, Part 1
Sean Fenske and Mike Drues share their thoughts on what the industry might be looking for in the coming year.Sean Fenske, Editor-in-Chief 12.04.18
-
Mike on Medtech: Regulating the Practice of Medicine
Sean Fenske and Mike Drues discuss the FDA's regulation of healthcare (or lack thereof) and if changes need to be made.Sean Fenske, Editor-in-Chief 10.26.18
-
Mike on Medtech: The Bleeding Edge, Part 3
The conversation on The Bleeding Edge documentary concludes in this portion of the three-part podcast series.Sean Fenske, Editor-in-Chief 09.26.18
-
Surgical
Mike on Medtech: The Bleeding Edge, Part 2
The discussion over the controversial Netflix documentary continues between Sean Fenske and Mike Drues in this episode.Sean Fenske, Editor-in-Chief 09.07.18
-
Surgical
Mike on Medtech: The Bleeding Edge, Part 1
Sean Fenske and Mike Drues begin a multi-part series on the controversial Netflix documentary on the medtech industry.Sean Fenske, Editor-in-Chief 09.05.18
-
Mike on Medtech: Breakthrough Designation Program
Sean Fenske and Mike Drues discuss the FDA's Breakthrough Designation Program and address common questions.Sean Fenske, Editor-in-Chief 08.10.18
-
Mike on Medtech: 15 Tips for Getting New Products Through FDA
Mike Drues provides insight to Sean Fenske on what he's learned about getting devices through the FDA over the last 15 years.Sean Fenske, Editor-in-Chief 07.03.18
-
Digital Health | Electronics
Mike on Medtech: Voice-Enabled Medtech
Sean Fenske and Mike Drues discuss voice-enabled medtech and its potential in healthcare.Sean Fenske, Editor-in-Chief 05.17.18
-
Mike on Medtech: Changing Pathway to Market?
Sean Fenske and Mike Drues discuss the changing MDR for CE mark and its impact on the “first to market” route companies take.Sean Fenske, Editor-in-Chief 04.25.18
-
3D/Additive Manufacturing
Mike on Medtech: 3D Printing Healthcare at the Point of Care
Sean Fenske and Mike Drues discuss the regulatory implications with 3D printing devices at a healthcare facility.Sean Fenske, Editor 03.23.18
follow us
Latest Breaking News From Nutraceuticals World
Longvida Curcumin May Help Reduce Pain and Lameness in Horses with OsteoarthritisParabel Launches Protein Hydrolysate from Water Lentils
Natural Remedies Earns GRAS Status for Turmacin
Latest Breaking News From Coatings World
Submit Abstracts for American Coatings Conference 2020Behr Reveals 2020 Color of the Year
Specialty Polymers Inc. Launches New Website
Latest Breaking News From Medical Product Outsourcing
New Contrast Agent Could Make MRIs SaferFDA OKs Profound Medical's TULSA-PRO for Prostate Tissue Ablation
Nanoscale 'Glass' Bottles Could Enable Targeted Drug Delivery
Latest Breaking News From Contract Pharma
Parker Bioscience Opens Doors to UK SiteRoche Wins Two Approvals for Cancer Drug Rozlytrek
Marker Therapeutics Appoints Regulatory Affairs VP
Latest Breaking News From Beauty Packaging
Here’s What Consumers Want Most from Skincare ProductsAriana Grande Launches New Fragrance
Natura & Co Doubles Net Income
Latest Breaking News From Happi
Innospec Expands Board of DirectorsSchedule Set for Sunscreen Symposium
Lebermuth Releases Guide To Upcoming IFRA Changes
Latest Breaking News From Ink World
Chromaflo Technologies Announces Organizational ChangesHeidelberg Appoints New CFO
Specialty Polymers Inc. Launches New Website
Latest Breaking News From Label & Narrow Web
PCMC acquires RDP Marathon and IPT DigitalAlbéa invests in fleet of Nilpeter presses
MCC labels help Bernini shine
Latest Breaking News From Nonwovens Industry
SINCE to Feature ConferenceSocial Media Campaign Targets Hygiene Products
Infinited Fiber Receives Lead Investment from RGE
